Next Article in Journal
Discovery of Marine Natural Products as Promising Antibiotics against Pseudomonas aeruginosa
Next Article in Special Issue
Porphyra tenera Protects against PM2.5-Induced Cognitive Dysfunction with the Regulation of Gut Function
Previous Article in Journal
Good Practices in Sponge Natural Product Studies: Revising Vouchers with Isomalabaricane Triterpenes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Novel Prenylated Indole Alkaloids with Neuroprotection on SH-SY5Y Cells against Oxidative Stress Targeting Keap1–Nrf2

1
National & Local Joint Engineering Research Centre of High-Throughput Drug Screening Technology, Hubei Key Laboratory of Biotechnology of Traditional Chinese Medicine, State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan 430062, China
2
College of Chemistry and Chemical Engineering, Hubei University, Wuhan 430062, China
3
Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Mar. Drugs 2022, 20(3), 191; https://doi.org/10.3390/md20030191
Submission received: 7 February 2022 / Revised: 28 February 2022 / Accepted: 1 March 2022 / Published: 4 March 2022
(This article belongs to the Special Issue Neuroprotective Effects of Marine Natural Products 2022)

Abstract

:
Oxidative stress has been implicated in the etiology of Parkinson’s disease (PD). Molecules non-covalently binding to the Keap1–Nrf2 complex could be a promising therapeutic approach for PD. Herein, two novel prenylated indole alkaloids asperpenazine (1), and asperpendoline (2) with a scarce skeleton of pyrimido[1,6-a]indole were discovered from the co-cultivated fungi of Aspergillus ochraceus MCCC 3A00521 and Penicillium sp. HUBU 0120. Compound 2 exhibited potential neuroprotective activity on SH-SY5Y cells against oxidative stress. Molecular mechanism research demonstrated that 2 inhibited Keap1 expression, resulting in the translocation of Nrf2 from the cytoplasm to the nucleus, activating the downstream genes expression of HO-1 and NQO1, leading to the reduction in reactive oxygen species (ROS) and the augment of glutathione. Molecular docking and dynamic simulation analyses manifested that 2 interacted with Keap1 (PDB ID: 1X2R) via forming typical hydrogen and hydrophobic bonds with residues and presented less fluctuation of RMSD and RMSF during a natural physiological condition.

Graphical Abstract

1. Introduction

As one of the most commonplace neurodegenerative movement disorders, Parkinson’s disease (PD) affects more than 10 million individuals worldwide [1]. A wealth of evidence indicated that oxidative stress, characterized by the excessive production of reactive oxygen species, may be directly or indirectly implicated in the etiology of PD [2,3,4]. It is commonly identified that nuclear factor (erythroid-derived 2)-like 2 (Nrf2) regulates the expression level of intracellular ROS and glutathione (GSH), which also is a positive transcriptional regulation factor for modulating the expression of genes carrying with antioxidant response elements (ARE) [5]. Normally, Nrf2 binds with Kelch-like ECH-associated protein 1 (Keap1), which sequesters the former in the cytoplasm to promote its degradation via the ubiquitylation system, then leads to blocking the nuclear translocation of Nrf2. Disruption of the Keap1–Nrf2 protein–protein interaction (PPI) was beneficial to release Nrf2, which stimulated Nrf2 translocating from cytoplasm to nucleus, binding to ARE, and then activating the antioxidative defense system to generate antioxidative enzymes such as heme oxygenase 1 (HO-1) and NADPH quinone oxidoreductase 1 (NQO1) [4]. Although accumulating research developed Nrf2 activators involving covalently bonding with Keap1, the small-molecule non-covalently targeting of the Keap1–Nrf2 complex may offer better safety owing to improved efficacy and selectivity [6,7].
Small molecules metabolized from fungi possess versatile skeletons, whose fascinating bioactivities of treating human maladies are well documented and have been an original driving force for continuously exploring lead drugs [8,9,10]. Prenylated indole alkaloids were obtained mainly from diverse species of Aspergillus and Penicillium fungi [10,11,12], presenting neuroprotective effects on SH-SY5Y cells or BV-2 cells and primary microglial cells [13,14,15]. During our ongoing pharmaceutical investigation on exploring new neuroprotective lead compounds from fungi [14,16], two novel prenylated indole alkaloids with diketopiperazine motif, termed asperpenazine (1) and asperpendoline (2) (Figure 1), were discovered from an ethyl acetate extract of co-cultured Aspergillus ochraceus and Penicillium sp. HUBU 0120. Structurally, compound 2 is an unexpected prenylated diketopiperazine derivative possessing the rare skeleton of pyrimido[1,6-a]indole, resulting from the key steps of putative biosynthesis such as indole oxidation, pinacol rearrangement, regiospecific N-prenylation at the indole ring [17], and intramolecular oxidation. Metabolites were screened for neuroprotective effects on H2O2-injured SH-SY5Y cells, which demonstrated compound 2 predominantly protected cells from an oxidative stress injury. Further mechanism studies implied that 2 attenuated ROS accumulation, augmented GSH level, suppressed Keap1 protein and mRNA expressions, enhanced Nrf2 protein expression in the nucleus, and then upregulated HO-1 and NQO1 protein and their mRNA expressions. We delineated herein the isolation, structural determination, plausible biosynthetic pathway, the pharmacologically active evaluation, and molecular simulation, which is elucidated in what follows.

2. Results and Discussion

The marine-derived fungus Aspergillus ochraceus and soil-derived Penicillium sp. HUBU 0120 were co-inoculated on the potato dextrose agar (PDA) for 7 days and then cultivated in Erlenmeyer flasks (150 × 500 mL) containing sterilized rice at 25 °C for one month (Figure S1). The ethyl acetate (EtOAc) extract was chromatographed exhaustively to afford novel prenylated indole alkaloids trivially termed asperpenazine (1) and asperpendoline (2).

2.1. Chemical Structure Elucidation

Asperpenazine (1), afforded as light-yellow needle crystals, whose molecular formula was deduced as C21H25N3O2 by the analysis of the high-resolution electrospray ionization mass spectroscopy (HRESIMS) with a quasimolecular ion at m/z 374.1903 ([M + Na]+ calcd. 374.1839). 1H and 13C nuclear magnetic resonance (NMR) spectra combining HSQC data analyses deciphered an ortho-disubstituted phenyl ring existence with the characteristic resonances [δC 126.7 (C-12), 118.4 (C-13), 120.1 (C-14), 122.5 (C-15), 111.2 (C-16), and 136.3 (C-17); δH 7.42 (d, J = 7.7 Hz, H-13), 7.06 (td, J = 7.6 and 1.1 Hz, H-14), 7.12 (td, J = 7.6 and 1.1 Hz, H-15), and 7.25 (d, J = 7.9 Hz, H-16)], four methyls [δC 26.2 (C-20), 19.1 (C-21), 19.0 (C-23), and 16.6 (C-24); δH 1.71 (d, J = 1.1 Hz, H-20), 1.98 (d, J = 1.1 Hz, H-21), 0.86 (d, J = 6.8 Hz, H-23), and 1.02 (d, J = 7.0 Hz, H-24)], one methylene [δC 28.2 (C-10); δH 3.46 (dd, J = 15.4 and 4.2 Hz, H-10a), and 2.87 (ddd, J = 15.3, 11.8, and 1.3 Hz, H-10b)], one sp2 methine [δC 120.7 (C-18); δH 5.27 (dt, J = 9.6 and 1.3 Hz, H-18)], four sp3 methines [δC 48.3 (C-3), 60.9 (C-6), 53.6 (C-9), and 32.7 (C-22); δH 6.45 (d, J = 9.5 Hz, H-3), 3.98 (brt, J = 2.4 Hz, H-6), 4.38 (dd, J = 11.7 and 4.0 Hz, H-9), and 2.38 (ddt, J = 10.5, 6.8, and 3.7 Hz, H-22)], two amide carbonyls [δC 163.8 (C-5) and 168.4 (C-8)], and three sp2 quaternary carbons [δC 132.6 (C-2), δC 106.6 (C-11), and δC 139.0 (C-19)]. Conjunction analysis of HSQC, 1H–1H COSY, and HMBC NMR data designated the 1H and 13C NMR signals of 1 (Table 1), which resulted in a proposal that 1 was likely to possess an indole diketopiperazine motif within [18,19]. 1H–1H COSY spin–spin systems of H-13/H-14/H-15/H-16, and HMBC correlations from H-13 to C-11/C-17 and from H-16 to C-12, together with the presence of a sp2 quaternary carbon [δC 132.6 (C-2)], roughly established an indole functional group (Figure 2). Further analyses of the HMBC data with the correlated resonances of H-6/C-5 and H-6/C-8, H-9/C-5 and H-9/C-8, and H-22/C-5 and H-22/C-6, along with the 1H–1H COSY coupling systems of H-6/H-22/H-23/H-24, constructed a diketopiperazine entity with an isopropyl group located at C-6. Finally, the HMBC spectrum with the correlated signals from H-3 to C-5, C-9, and C-11, and from H-10 to C-2, C-8, and C-9, connected the aforementioned motifs to the indole diketopiperazine skeleton with the C-3 isobutenyl substituent, forming an atypical fumitremorgin-type alkaloid [12], due to the HMBC correlations from Me-20 (and Me-21) to C-18 and C-19, and from H-18 to C-3, C-20, and C-21 (Figure 2).
The NOESY experiments were then performed to deduce the relative stereo-characteristics of 1 (Figure 2). Pivotal NOESY cross-peaks of H-6/H-9 and H-9/H-10a permitted an equatorial direction for these protons as an α-oriented assignment. Attributed to the key signal absence between H-3 and H-9, the signal of H-3/H-10b observed in the NOESY spectrum suggested the axial-directed for H-3 and H-10b as the β orientation. Completely, the absolute stereochemistry confirmation was finished via the single-crystal X-ray diffraction spectroscopy (XRD) on the single crystal of 1. The chiral features of C-3, C-6, and C-9 were established as 3R,6S,9S (Figure 3), since the XRD data were collected with CuKα radiation, providing the Flack parameter of 0.08(4) (CCDC 2070312).
Asperpendoline (2) was isolated as a greenish-yellow powder with the molecular formula C22H27N3O4, possessing the eleven degrees of unsaturation, which was deduced by the HRESIMS positive ion peak at m/z 420.1897 ([M + Na]+ calcd. 420.1894). Interpretation of the 1H, 13C, and DEPT NMR spectra along with HSQC correlations provided the 1H and 13C chemical shift assignments of 2 (Table 1). The 1D and HSQC NMR spectra deduced the presence of 1,2-disubstituted phenyl ring with the typical resonances [δC 119.6 (C-12), 125.5 (C-13), 120.3 (C-14), 138.7 (C-15), 110.7 (C-16), and 157.7 (C-17); δH 7.59 (d, J = 8.0 Hz, H-13), 6.87 (t, J = 7.5 Hz, H-14), 7.55 (d, J = 7.7 Hz, H-15), and 7.17 (d, J = 8.4 Hz, H-16)], four methyls [δC 26.1 (C-20), 18.8 (C-21), 18.7 (C-23) and 16.0 (C-24); δH 1.79 (s, Me-20), 1.91 (s, Me-21), 0.88 (d, J = 7.1 Hz, Me-23), and 0.52 (d, J = 6.8 Hz, Me-24)], one methoxyl [δC 52.0 (C-25); δH 3.14 (s, Me-25)], one methylene [δC 36.4 (C-9); δH-9a 1.53 (t, J = 13.2 Hz) and δH-9b 2.64 (dd, J = 13.8 and 2.6 Hz)], four sp3 methines [δC 58.5 (C-2), 60.1 (C-5), 48.9 (C-8), and 32.2 (C-22); δH 7.23 (d, J = 9.8 Hz, H-2), 3.91 (brt, J = 2.4 Hz, H-5), 4.66 (dd, J = 13.0 and 2.3 Hz, H-8), and 2.29 (ddt, J = 13.7, 7.0, and 3.2 Hz, H-22)], one sp2 methine [δC 117.9 (C-18); δH 5.77 (d, J = 8.6 Hz, H-18)], one oxygenated carbon [δC 91.1 (C-10)], two amide carbonyls [δC 163.0 (C-4) and 166.6 (C-7)], one carbonyl [δC 198.4 (C-11)], and one sp2 quaternary carbon [δC 139.4 (C-19)]. Based on the 1H–1H COSY and HMBC NMR signals and the shift value analyses, the indolin-3-one unit presented in 2 rather than the indole motif as in 1, was substantiated by the 1H–1H COSY coupling systems of H-13/H-14/H-15/H-16, the HMBC signals between H-13 and C-11/C-17, H-15 and C-17, and H-16 and C-12, and particularly, the presence of the C-10−N-1 bond, which reasonably supported the unusual downfield shift of C-10 (δC 91.1), although as an oxygenated carbon, C-10, with a methoxyl substituent resulting from the HMBC cross-peaks of Me-25/C-10 (Figure 2). Compound 2 has the identical diketopiperazine unit along with a C-6 isopropyl substituent to 1, which is confirmed by the similar chemical shift values of C-4, C-5, C-7, C-8, C-22, C-23, and C-24, to those of 1, and the HMBC correlated signals of H-5 to C-4 and C-7, H-8 to C-4 and C-7, and H-22 to C-5, as well as the 1H–1H COSY signals of H-5/H-22/H-23/H-24 observed in the spectrum. Furthermore, the key correlations in the HMBC spectrum of H-2 to C-4, C-10, and C-17, and H-9 to C-7, C-10, and C-11, as well as the COSY cross-peak of H-8/H-9, demonstrated the fusion of the indolin-3-one unit with the diketopiperazine motif, meeting the eleven indices of hydrogen deficiency, along with the isobutenyl functional group at C-2 for the observed signals of Me-20/21 to C-18 and C-19, and H-18 to C-2, C-20, and C-21 in the HMBC correlations (Figure 2). Architecturally, to the best of our knowledge, 2 with an unprecedented skeleton, which was forged via C-9–C-10–N-1–C-2 incorporating the indoline into the diketopiperazine motif, forming the scarce skeleton of pyrimido[1,6-a]indole, rather than via C-10–C-11=C-12–C-3 combination such as in that reported ones [18,19].
Detailed NOESY correlation analyses revealed the relative chiral features of 2. The observed key signals in the NOESY spectrogram of H-5/H-8, H-8/H-18, and Me-25/H-18 suggested that these protons were co-facial, and then H-5, H-8, and the C−O bond were arbitrarily designated as the α orientation. As in the six-membered ring unit, the absence of NOESY cross-peaks of Me-25/H-2, Me-25/H-8, and H-2/H-8 illustrated the β orientation of H-2, which could be further supported due to the upfield shift of C-2 (δC 58.5) resulting from the γ-gauch effect. Therefore, the relative configuration as 2S*,5R*,8R*,10R*-2 was constructed, and then the quantum chemical prediction on the 13C NMR shifts of which was executed via scaling methods [20,21] at the mPW1PW91/6-31G(d)-SCRF//M062X/6-31G(d) level. The calculated chemical shifts (δ) were obtained via the equation δ = (intercept − σ)/(−slope) (σ was the calculated isotropic value for a given nucleus; the values of the intercept and the slope were 193.2179 and −0.9537, respectively) [21], and then constructed the linear regression correlations between the calculated with the experimental 13C NMR shifts to acquire scaled calculated NMR shifts (Scal. Calc) (Table S1). The results with the high R2 value of 0.9991 (Figure 4A), the low average absolute deviation (AveDev) of 1.25, and the maximum absolute deviation (MaxDev) of 4.09 (Table S1), strongly supported the proposed relative configuration. Subsequently, the electronic circular dichroism (ECD) calculation was performed at the CAM-B3LYP-SCRF/def2-TZVPP//PBE0-SCRF/6-311G(d,p) level to simulate the Cotton effects of 2, using the Gaussian 16 program. ECD simulation results matched well with the experimental curve (Figure 4B), which implied the absolute structure assignment 2S,5R,8R,10R of 2.
Prenylated indole alkaloids, as well as derivatives thereof, whose skeletons are biogenetically originated from the condensation product involving tryptophan and other amino acids biocatalyzed by the nonribosomal peptide synthetase (NPS) [10,11,12]. The putative biosynthetic routes of compounds 1 and 2 are proposed in Figure 5. Firstly, tryptophan and valine occur condensation to form the key intermediate i via NPS catalyzation, which then proceeds along the following pathways. After bearing the prenylation via the dimethylallyl pyrophosphate (DMAPP) with the prenyltransferase [22], i successively undergoes cyclization to form intermediate ii, which then endures an intramolecular oxidative ring-closure reaction, a pivotal step involving C-3−N-4 bond formation mediated by the cytochrome P450 monooxygenase [23,24], and finally affording 1. Alternatively, intermediate i occurs the oxidation attributable to indole oxidase catalyzation [10], Wagner–Meerwein rearrangement, and methoxylation involving O-methyltransferase due to structurally owning nucleophilic characteristics, to yield intermediate iii. Then, iii is regiospecifically N-prenylated by DMAPP at the indole ring [17], forming intermediate iv, which consecutively bears the aforementioned procedures, resulting in compound 2.

2.2. Neuroprotection on SH-SY5Y Cells against Oxidative Stress

Compounds 1 and 2 contain carboline motifs incorporated into diketopiperazine units, both of which are considered favorable templates for the drug scaffolds design [25]. As human dopaminergic cells, SH-SY5Y cells have been typically applied on neuroprotection evaluation and molecular mechanism studies [26]. H2O2, a major ROS, is involved in neurodegenerative maladies including PD, which has been universally used to insult neuronal cells for the investigation of neuron injury under the oxidative stress condition [27,28]. The cytotoxicities of 1 and 2 on SH-SY5Y cells were firstly examined using the CCK-8 assay, and both compounds presented no cytotoxic activity with the concentration of 50 μM, whereas the positive control tert-butylhydroquinone (TBHQ) showed such activity (Figure 6A). The concentration of 50 μM thereby was adopted as the maximum one for isolates in the subsequent neuroprotection assessments. Then, the protection from H2O2 injury on cells of compounds was evaluated, and as shown in Figure 6B, both metabolites exhibited cytoprotective activity in dose-dependently on H2O2-induced cells, with 2 being more efficacious at the concentration of 50 μM than TBHQ at 10 μM. The overexpression of intracellular ROS plays a pivotal role in the proceeding of neuronal cells death via H2O2 insult [29]. DCFH–DA fluorescence staining and photography were carried out to assess the ROS level, and as shown in Figure 6C,D, with the concentration of 50 μM, 2 restored the morphology of H2O2-injured cells and attenuated the fluorescence intensity produced by ROS. As one of the most plentiful endogenous antioxidants, GSH has an essential effect on ROS detoxification and redox homeostasis regulation [30]. The level of GSH was determined using ELISA assay, and as Figure 6E shows, 2 promoted GSH concentration in a dose-dependent manner toward H2O2-induced cells.
The activation of antioxidative genes of Nrf2, such as HO-1 and NQO1, predominantly depends on the nuclear translocation of Nrf2 [31]. Based on the immunofluorescence assay, the effect of 2 toward Nrf2 translocation in cells from the cytosol to the nucleus was measured. The results showed that the 2-treated group distinctly increased translocation of Nrf2 for the green fluorescence in the nucleus of cells (Figure 7A). Furthermore, Nrf2 expression in the cytosol, and the nucleus after cells treated with or without 2 was also detected via Western blotting. The level of cytosolic and nuclear Nrf2 protein exhibited the reverse trend in control and H2O2-insult groups, while consistent uptrend presented after H2O2-induced cells were administrated 2 with the concentrations ranging from 10–50 μM (Figure 7B), which may be attributable to disturbance of Keap1–Nrf2 PPI by 2, releasing Nrf2 from ubiquitylation system. As phase-II detoxification enzymes, HO-1 and NQO1 are regulated by Nrf2, which is translocated into the nucleus and combines ARE to activate genes transcription of the formers. The further assessments of protein and mRNA expression on Keap1, HO-1, and NQO1 were measured using Western blotting and qRT–PCR assays, respectively. The protein expression levels of both HO-1 and NQO1 were enhanced, the ones of Keap1 were suppressed, along with the consistent expression trends of their mRNA levels, when H2O2-injured cells were treated with 2 (10–50 μM) (Figure 7C–F). Taken together, against H2O2-induced oxidative stress in SH-SY5Y cells, 2 inhibited expression of Keap1, leading to nuclear translocation of Nrf2, then inducing HO-1 and NQO1 expression via Nrf2 activation, which resulted in a reduced level of ROS and an augmented level of GSH, protecting cells from oxidative damage.

2.3. Molecular Docking and Dynamics Simulation of 2–1X2R

The molecular docking approach is widely used to predict reliable binding dispositions between ligands and target proteins. As shown by the aforementioned results, 2 may target Keap1–Nrf2 PPI to modulate the Nrf2 signaling pathway, achieving neuroprotection toward SH-SY5Y cells from oxidative stress. Computational docking and molecular dynamics simulation, therefore, were carried out to predict the binding characteristics between 2 and Keap1 (PDB ID: 1X2R). The procedure of AutoDock 4.2.6 with MGLTools 1.5.6 (ADT) was performed for the virtual docking, which showed that 2 presented a high negative binding affinity (−8.46 kcal/mol), together with a low inhibition constant (Ki) (632.06 nM) docking with 1X2R. The binding perspective of the 2–1X2R complex was visualized via PyMOL Molecular Graphics System 2.4 and Discovery Studio 2020 (DS20). As shown in Figure 8, 2 bonded with 1X2R in a non-covalent manner, forming typical hydrogen bonds with amino acid residues of Val608, Val369, Val418, Val465, and Val467 along with the respective distance of 2.1, 2.2, 1.8, 3.0, and 2.3 Å, and hydrophobically interacting with residues of Cys513, Ala466, and Val420.
To examine the stability of the docked 2–1X2R complex during physiological conditions, the molecular dynamics simulation (MDS) program of DS20 was used to calculate the root-mean-square deviation (RMSD) of the conformational stabilities over time and the root-mean-square fluctuation (RMSF) of the protein backbone atoms. After 4 ps CHARMm force field minimization and 200 ps of solvent equilibration, 2–1X2R still exhibited thermal stability at 300 K from 204 ps to 2204 ps with the total energies from −59,517 to −59,919 kcal/mol. The average values of RMSD, RMSF, main-chain RMSF, and side-chain RMSF of the complex were detected as 1.70, 0.98, 0.83, and 1.01 Å, respectively (Figure 9), which illustrated the stabilization of the docked 2–1X2R with less conformational fluctuations within a natural environment.

3. Materials and Methods

3.1. General Experimental Procedures

HRESIMS data were collected on a Bruker micro TOF II and SolariX 7.0 spectrometer (Bruker, Karlsruhe, Germany). Ultraviolet–visible (UV–Vis) absorption spectroscopy data were measured using a Bruker Vertex 70 spectrometer (Brucker Co., Karlsruhe, Germany). Infrared (IR) spectra were detected by a Fourier transform infrared spectrometer (Varian Cary 50 FT-IR, Varian Medical Systems, Salt Lake City, UT, USA). Optical rotation measurements were performed on a JASCO P-2200 digital polarimeter (JASCO, Tokyo, Japan) at 20 °C. ECD spectra were determined by a JASCO J-810 spectrometer (JASCO, Tokyo, Japan). The Bruker AM-400 spectrometer (Brucker Co., Karlsruhe, Germany) was performed to collect 1H NMR (400 MHz) and 13C NMR (100 MHz) data of compounds, whose chemical shifts were obtained in ppm via referring to the solvent peaks (CDCl3, δH 7.24 and δC 77.23). XRD data were recorded by a Bruker APEX DUO diffractometer (Brucker Co., Karlsruhe, Germany) with graphite-monochromated CuKα radiation. Silica gel (200–300 mesh) and reversed-phase C18 (RP-C18, spherical, 20 μM) were purchased from Santai Technologies, Inc., Suzhou, China. Sephadex LH-20 was afforded by Beijing Solarbio Science and Technology Co., Ltd., China. Thin-layer chromatography (TLC) was fulfilled using silica gel 60 F254 (GF254) (Qingdao Haiyang Chemical Co., Ltd., Qingdao, China). The semi-preparative high-performance liquid chromatography (HPLC) instrument (Waters 600, Milford, MA, USA) was performed to repurify compounds 1 and 2 over a Shim-Pack GIST-C18 column (5 μM, 10 × 250 mm, Shimadzu (Shanghai, China) Global Laboratory Consumables Co., Ltd., Shanghai, China).

3.2. Strain Material

Aspergillus ochraceus MCCC 3A00521, derived from the deep-sea water in the Pacific Ocean, the voucher specimens of which were provided by Marine Culture Collection of China. Penicillium sp. HUBU 0120, collected from the soil of Xishan Mountain, Kunming, Yunnan Province, China in May 2018, the identification of which was accomplished referring to the morphological features, and the sequence analyses of the internal transcribed spacer (ITS) region of the ribosomal RNA (rDNA) using ITS 1 and ITS 4, and the sequence data of which were submitted to GenBank with the accession number MW463395. Based on the BLAST consequences of ITS genes in NCBI, the phylogenetic tree of Penicillium sp. HUBU 0120 was constructed via MEGA 7.0 software using the neighbor-joining (N-J) method (Figure S2). The inoculated fungus A. ochraceus MCCC 3A00521 was deposited in the Strain Preservation Center, School of Life Sciences, Hubei University, China. The fungus P. sp. HUBU 0120 was preserved in China Center for Type Culture Collection, Wuhan University, China (preservation ID: CCTCC M2021412).

3.3. Fermentation, Extraction and Isolation

The co-cultured fungi of A. ochraceus MCCC 3A00521 and P. sp. HUBU 0120 were inoculated in PDA culture plates at 25 °C for a week. The agar containing two fungi was divided into small pieces and then subjected to sterilized Erlenmeyer flasks (150 × 500 mL), which were pre-added with 100 g rice, 150 mL H2O, 0.8% NaCl, 0.5% KCl, and 0.8% MgSO4, fermenting at 25 °C for 30 days. Then, the growing fungi were sequestered by adding 150 mL EtOAc to each flask. The fermentation was extracted six times using EtOAc (6 × 10 L) and then yielded a crude extract (400 g) under the vacuum evaporation. Subsequently, the extract was subjected to a silica gel column (silica gel 4.0 kg, column 20 × 150 cm), eluting with petroleum ether, methylene chloride (CH2Cl2), and EtOAc, in turn. The methylene chloride partition (100 g) was fractionated into seven fractions (Fr1–Fr7) by column chromatography (CC) with silica gel (2.0 kg, 15 × 100 cm), eluting with CH2Cl2−CH3OH (300:1 → 10:1). After being detected with TLC, the fraction Fr4 (10 g) was selected and partitioned into six subfractions of Fr4.1–Fr4.6 by the gradient elution on the medium pressure liquid chromatography (MPLC, RP-C18, 5 × 50 cm) with MeOH−H2O (10:90 → 100:0). The subfraction Fr4.4 (2 g) was subjected to the Sephadex LH-20 CC (4 × 185 cm, MeOH) to obtain five subparts (Fr4.4.1–Fr4.4.5). The subpart Fr4.4.2 (400 mg) was obtained after removing the solvent using vacuum evaporation. Finally, Fr4.4.2 was further repurified by HPLC (MeOH–H2O, v/v 45:55, 2.0 mL/min, 254 nm) over a semi-preparative Shim-Pack GIST-C18 column to yield 1 (15 mg; retention time: 35 min) and 2 (5 mg; retention time: 55 min).
Asperpenazine (1):
light-yellow needle crystals; [ α ] D 20 −283.4 (c 0.53, CH3OH); UV (CH3OH) λmax (log ε) 227 (4.77) and 272 (4.03) nm; IR (KBr) νmax 3279, 3059, 2963, 1679, 1450, and 1327 cm–1; ECD λmax (∆ε) 216 (−12.16) and 269 (−3.62) nm (the experimental ECD spectrum was shown in Figure S3); 1H and 13C NMR data, see Table 1; HRESIMS: m/z 374.1903 [M + Na]+ (calcd for C21H25N3O2Na, 374.1839). HRESIMS, UV, IR, and NMR spectra of 1 were shown in Figures S4–S13.
Asperpendoline (2):
greenish-yellow powder; [ α ] D 20 +96.8 (c 0.24, MeOH); UV (CH3OH) λmax (log ε) 238 (4.61) and 399 (3.73) nm; IR (KBr) νmax 3215, 2926, 1722, 1685, 1583, 1466, 1441, and 1319 cm–1; ECD λmax (∆ε) 237 (−8.63), 261 (+4.09), 334 (−5.63), and 382 (+6.90) nm; 1H and 13C NMR data, see Table 1; HRESIMS: m/z 420.1897 [M + Na]+ (calcd for C22H27N3O4Na, 420.1894). HRESIMS, UV, IR, and NMR spectra of 2 were shown in Figures S14–S23.

3.4. Single-Crystal X-ray Data for Asperpenazine (1)

C21H25N3O2•H2O, M = 369.45, a = 8.9067(2) Å, b = 13.3081(3) Å, c = 15.9542(3) Å, α = 90°, β = 90°, γ = 90°, V = 1891.07(7) Å3, T = 100.(2) K, space group P212121, Z = 4, μ(Cu Kα) = 0.706 mm−1, 20,318 reflections measured, 3708 independent reflections (Rint = 0.0294). The final R1 values were 0.0283 (I > 2σ(I)). The final wR(F2) values were 0.0722 (I > 2σ(I)). The final R1 values were 0.0284 (all data). The final wR(F2) values were 0.0723 (all data). The goodness of fit on F2 was 1.100. Flack parameter = 0.08(4).

3.5. Cytotoxicity and Cytoprotection Evaluation

The SH-SY5Y cell line was kindly provided by the Institute of Materia Medica, the Chinese Academy of Medical Sciences, and Peking Union Medical College. The cytotoxicity and cytoprotection of compounds on SH-SY5Y cells treated with or without H2O2 were determined using a CCK-8 assay. The detailed experiments were described in previous studies [14,16]. The CCK-8 kit was purchased from Beyotime Biotechnology Co., Ltd., Shanghai, China. Briefly, inoculated cells in 96-well plates were treated without or with H2O2 (350 μM) or being co-treated with H2O2 (350 μM) and compounds with designated concentrations in the incubator under 5% CO2 at 37 °C for 24 h. As cells grew to 75% confluence, the CCK-8 solution (10 μL) was then added and cultivated for 2 h. The envision 2104 multilabel reader (PerkinElmer, Waltham, MA, USA) was used to measure the optical density (OD) at 450 nm of each well. The cell viabilities were evaluated via the formula:
Cell viability% = [OD(experimental group) − OD(blank)]/[OD(control group) − OD(blank)] × 100% (means ± SD, n = 3).

3.6. ROS Level Evaluation

The intracellular ROS level of cells was determined by the ROS assay kit (Beyotime Biotechnology Co., Ltd., Shanghai, China) with the DCFH–DA as the probe [32], according to the protocol afforded by the manufacturer. After being treated without or with H2O2 (350 μM), or co-treated with H2O2 (350 μM) and 2 (10, 25, and 50 μM) for 24 h, cells were washed and then stained with a diluted DCFH–DA solution in dark for 20 min. A fluorescence microscope was used to observe and photograph cells. The value of integrated OD for each group was recorded for the expression of the fluorescence intensity.

3.7. GSH Level Evaluation

The GSH produced in cells was assessed through the GSH ELISA assay kit (ELK Biotechnology Co., Ltd., Wuhan, China), following the protocol provided by the manufacturer. The procedures in this assay were executed as previously described [16].

3.8. Nuclear Translocation of Nrf2

The microscopy immunofluorescence staining method was used in the Nrf2 translocation assay. Firstly, cells were cultured with or without 2 (50 μM) for 24 h, fixed with paraformaldehyde (4%) for 20 min. Then, cells were successively permeabilized using 0.1% Triton X-100, washed by PBS, and blocked with BSA (bovine serum albumin, 5%). After being treated with the primary antibody Nrf2 (Wuhan Sanying Biotechnology Co., Ltd., Wuhan, China) and secondary antibody (Wuhan Sanying Biotechnology Co., Ltd., Wuhan, China), cells were lastly stained by DAPI (Beyotime Biotechnology Co., Ltd., Shanghai, China). The photographs of cells were captured under the fluorescence microscope.

3.9. Western Blotting

The procedures of cells cultivation and treatment were identical to the above mentioned. The radioimmunoprecipitation (RIPA) assay was carried out to yield the lysates of cells, which were then centrifugated at 12,000 rpm for 5 min to obtain the supernatant for immunoblot analyses. The total protein concentrations were measured by the BCA kit (Aspen Biotechnology Co., Ltd., Wuhan, China) according to the instruction provided by the manufacturer. The procedures of the electrophoresis and Western blotting analyses referenced the reported literature [33].

3.10. Quantitative Real-Time Reverse Transcriptase—Polymerase Chain Reaction (qRT−PCR)

Cells treated without or with H2O2 (350 μM) alone or co-treated with H2O2 (350 μM) and 2 with doses ranging from 10–50 μM for 24 h and then harvested in TRIpure total RNA extraction reagent (ELK Biotechnology Co., Ltd., Wuhan, China). The cDNA was probed after reverse transcription via the EntiLink™ Reverse Transcriptase kit (ELK Biotechnology Co., Ltd., Wuhan, China) with the oligo(dT)12–18 primers. The primers in this research were synthesized by Wuhan Jin-Kai-Rui Biological Engineering Co., Ltd., Wuhan, China. The primer information is shown in Table S2. According to the protocol of the EnTurboTM SYBR Green PCR SuperMix kit (ELK Biotechnology Co., Ltd., Wuhan, China), the qRT−PCR experiments were performed on a StepOneTM Real-Time PCR detection system (Life Technologies Corp., Carlsbad, CA, USA).

3.11. Molecular Docking

The molecular docking study on the binding dispositions between 2 and Keap1 (PDB ID: 1X2R) was performed using AutoDock 4.2.6 with MGLTools 1.5.6 (ADT). The details of the docking procedures were delineated in our previous research [14]. The coordinates of grid box size were determined via the AutoGrid program and designated at 126 × 126 × 126 (x, y, and z) points, centered at x, y, and z dimensions of −23.558 × −4.445 × 12.356, as well as the grid spacing set at 0.375 Å. The docking between 2 and 1X2R was executed using the default parameters of the ADT program.

3.12. Molecular Dynamics Simulation

The approach of the MDS on 2–1X2R was shown in detail in a reported study [14]. The standard dynamics module in DS20 was carried out. The 2–1X2R complex was assigned a CHARMm force field. Then, the solvation module for the complex was performed using the default parameters to simulate a natural physiological environment. Finally, the standard dynamics cascade program was performed under an equilibration time of 200 ps and a production time of 2000 ps with 32 processors. Other parameters were set as default values of the program.

4. Conclusions

In the present study, two novel prenylated indole alkaloids asperpenazine (1) and asperpendoline (2), with diketopiperazine motifs, were discovered from the co-cultivated fungi of A. ochraceus MCCC 3A00521 and P. sp. HUBU 0120. In particular, 2 possessed an unprecedented skeleton, incorporating the indoline into the diketopiperazine motif to forge a scarce skeleton of pyrimido[1,6-a]indole. The plausible biogenetic pathway suggested that the indole oxidase catalyzation, Wagner–Meerwein rearrangement, methoxylation, and regiospecific N-prenylation should be involved. Furthermore, compound 2 exhibited promising neuroprotective effects on SH-SY5Y cells from oxidative damage, which may be attributable to 2 non-covalently binding with Keap1, resulting in the nuclear translocation of Nrf2 to activate the expression of HO-1 and NQO1, then attenuating the ROS accumulation and enhancing the GSH level. Computational molecular docking and dynamic simulation analyses demonstrated that 2 formed typical hydrogen and hydrophobic bonds with residues of Keap1, presenting less fluctuation of RMSD and RMSF during a general physiological circumstance. Thus, compound 2 will shed light on the skeleton design of novel neuroprotective drugs non-covalently bonding with Keap1–Nrf2.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/md20030191/s1, Figure S1: The co-cultured and the fermentation of fungi, Figure S2: Penicillium sp. HUBU 0120 and the phylogenetic tree of ITS genes, computational details of 2, Figure S3: The experimental ECD spectrum of 1, Table S1: Deviations between the calculated and the experimental 13C NMR chemical shifts for 2, Table S2: Primer information of Keap1, HO-1, NQO-1, Histone H3, and β-Actin, Figures S4–S23: HRESIMS, UV, IR, 1H NMR, 13C NMR, DEPT 135, HSQC, HMBC, 1H–1H COSY, and NOESY spectra of compounds 1 and 2, and X-ray crystallographic data of 1 in CIF format were also included. References [34,35,36] are cited in the supplementary materials.

Author Contributions

Project administration and writing—original draft preparation, L.H.; conceptualization and writing—review and editing, Z.H.; methodology, X.X., Z.T. and Y.Z.; formal analysis, H.Z., M.L. and T.H.; investigation, P.H. and L.K.; resources, Z.L. and C.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research was financially supported by the National Natural Science Foundation of China (No. 31700298), the National and Local Joint Engineering Research Center of High-throughput Drug Screening Technology (Hubei Province, China) (No. M20202001), and the Innovation and Entrepreneurship Training Program for Undergraduates (Hubei Province, China) (No. S202010512054).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

DEPTDistortionless enhancement by polarization transfer
HSQC1H detected heteronuclear single quantum coherence spectroscopy
HMBC1H detected heteronuclear multiple bond connectivity spectroscopy
1H–1H COSY1H–1H chemical shift correlated spectroscopy
NOESYNuclear overhauser effect spectroscopy
ORTEPOak ridge thermal ellipsoid plot
CCK-8Cell counting kit-8
DCFH–DA2,7-Dichlorodihydrofluorescein diacetate
ELISAEnzyme-linked immunosorbent assay
DAPI4′,6-Diamidino-2-phenylindole

References

  1. Gao, C.; Sun, H.; Wang, T.; Tang, M.; Bohnen, N.I.; Müller, M.L.; Herman, T.; Giladi, N.; Kalinin, A.; Spino, C.; et al. Model-based and model-free machine learning techniques for diagnostic prediction and classification of clinical outcomes in Parkinson’s disease. Sci. Rep. 2018, 8, 7129. [Google Scholar] [CrossRef]
  2. Nikam, S.; Nikam, P.; Ahaley, S.K.; Sontakke, A.V. Oxidative stress in Parkinson’s disease. Indian J. Clin. Biochem. 2009, 24, 98–101. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Thanan, R.; Oikawa, S.; Hiraku, Y.; Ohnishi, S.; Ma, N.; Pinlaor, S.; Yongvanit, P.; Kawanishi, S.; Murata, M. Oxidative stress and its significant roles in neurodegenerative diseases and cancer. Int. J. Mol. Sci. 2014, 16, 193–217. [Google Scholar] [CrossRef] [Green Version]
  4. Gan, L.; Johnson, J.A. Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases. Biochim. Biophys. Acta 2014, 1842, 1208–1218. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Silva, M.M.; Rocha, C.R.R.; Kinker, G.S.; Pelegrini, A.L.; Menck, C.F.M. The balance between NRF2/GSH antioxidant mediated pathway and DNA repair modulates cisplatin resistance in lung cancer cells. Sci. Rep. 2019, 9, 17639. [Google Scholar] [CrossRef] [PubMed]
  6. Leung, C.H.; Zhang, J.T.; Yang, G.J.; Liu, H.; Han, Q.B.; Ma, D.L. Emerging screening approaches in the development of Nrf2-Keap1 protein-protein interaction inhibitors. Int. J. Mol. Sci. 2019, 20, 4445. [Google Scholar] [CrossRef] [Green Version]
  7. Pallesen, J.S.; Tran, K.T.; Bach, A. Non-covalent small-molecule Kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 (Keap1-Nrf2) inhibitors and their potential for targeting central nervous system diseases. J. Med. Chem. 2018, 61, 8088–8103. [Google Scholar] [CrossRef]
  8. Scherlach, K.; Hertweck, C. Triggering cryptic natural product biosynthesis in microorganisms. Org. Biomol. Chem. 2009, 7, 1753–1760. [Google Scholar] [CrossRef]
  9. Schueffler, A.; Anke, T. Fungal natural products in research and development. Nat. Prod. Rep. 2014, 31, 1425–1448. [Google Scholar] [CrossRef]
  10. Finefield, J.M.; Frisvad, J.C.; Sherman, D.H.; Williams, R.M. Fungal origins of the bicyclo[2.2.2]diazaoctane ring system of prenylated indole alkaloids. J. Nat. Prod. 2012, 75, 812–833. [Google Scholar] [CrossRef] [Green Version]
  11. Williams, R.M.; Stocking, E.M.; Sanz Cervera, J.F. Biosynthesis of prenylated alkaloids derived from Tryptophan. Topics Curr. Chem. 2000, 209, 97–173. [Google Scholar]
  12. Li, S.M. Genome mining and biosynthesis of fumitremorgin-type alkaloids in ascomycetes. J. Antibiot. 2011, 64, 45–49. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Lin, Z.; Wen, J.; Zhu, T.; Fang, Y.; Gu, Q.; Zhu, W. Chrysogenamide A from an endophytic fungus associated with Cistanche deserticola and its neuroprotective effect on SH-SY5Y cells. J. Antibiot. 2008, 61, 81–85. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Hu, L.; Tian, S.; Wu, R.; Tong, Z.; Jiang, W.; Hu, P.; Xiao, X.; Zhang, X.; Zhou, H.; Tong, Q.; et al. Identification of anti-Parkinson’s disease lead compounds from Aspergillus ochraceus targeting adenosin receptors A2A. ChemistryOpen 2021, 10, 630–638. [Google Scholar] [CrossRef]
  15. Zhang, C.; Hu, L.; Liu, D.; Huang, J.; Lin, W. Circumdatin D exerts neuroprotective effects by attenuating LPS-induced pro-inflammatory responses and downregulating acetylcholinesterase activity in vitro and in vivo. Front. Pharmacol. 2020, 11, 760. [Google Scholar] [CrossRef]
  16. Tong, Z.; Xiao, X.; Lu, Y.; Zhang, Y.; Hu, P.; Jiang, W.; Zhou, H.; Pan, S.; Huang, Z.; Hu, L. New metabolites from Aspergillus ochraceus with antioxidative activity and neuroprotective potential on H2O2 insult SH-SY5Y cells. Molecules 2022, 27, 52. [Google Scholar] [CrossRef]
  17. Grundmann, A.; Kuznetsova, T.; Afiyatullov, S.; Li, S.M. FtmPT2, an N-prenyltransferase from Aspergillus fumigatus, catalyses the last step in the biosynthesis of fumitremorgin B. ChemBioChem 2008, 9, 2059–2063. [Google Scholar] [CrossRef]
  18. Xie, F.; Li, X.B.; Zhou, J.C.; Xu, Q.Q.; Wang, X.N.; Yuan, H.Q.; Lou, H.X. Secondary metabolites from Aspergillus fumigatus, an endophytic fungus from the Liverwort Heteroscyphus tener (Steph.) Schiffn. Chem. Biodivers. 2015, 12, 1313–1321. [Google Scholar] [CrossRef]
  19. He, X.; Ding, L.; Yi, M.; Xu, J.; Zhou, X.; Zhang, W.; He, S. Separation of five diketopiperazines from the marine fungus Alternaria alternate HK-25 by high-speed counter-current chromatography. J. Sep. Sci. 2019, 42, 2510–2516. [Google Scholar] [CrossRef]
  20. Li, J.; Liu, J.K.; Wang, W.X. GIAO 13C NMR Calculation with sorted training sets improves accuracy and reliability for structural assignation. J. Org. Chem. 2020, 85, 11350–11358. [Google Scholar] [CrossRef]
  21. Lodewyk, M.W.; Siebert, M.R.; Tantillo, D.J. Computational prediction of 1H and 13C chemical shifts: A useful tool for natural product, mechanistic, and synthetic organic chemistry. Chem. Rev. 2012, 112, 1839–1862. [Google Scholar] [CrossRef] [PubMed]
  22. Maiya, S.; Grundmann, A.; Li, S.M.; Turner, G. The fumitremorgin gene cluster of Aspergillus fumigatus: Identification of a gene encoding brevianamide F synthetase. ChemBioChem 2006, 7, 1062–1069. [Google Scholar] [CrossRef] [PubMed]
  23. Kato, N.; Suzuki, H.; Takagi, H.; Asami, Y.; Kakeya, H.; Uramoto, M.; Usui, T.; Takahashi, S.; Sugimoto, Y.; Osada, H. Identification of cytochrome P450s required for fumitremorgin biosynthesis in Aspergillus fumigatus. ChemBioChem 2009, 10, 920–928. [Google Scholar] [CrossRef] [PubMed]
  24. Han, J.; Liu, M.; Jenkins, I.D.; Liu, X.; Zhang, L.; Quinn, R.J.; Feng, Y. Genome-inspired chemical exploration of marine fungus Aspergillus fumigatus MF071. Mar. Drugs 2020, 18, 352. [Google Scholar] [CrossRef]
  25. Dolle, R.E. Comprehensive survey of chemical libraries yielding enzyme inhibitors, receptor agonists and antagonists, and other biologically active agents: 1992 through 1997. Mol. Divers. 1998, 3, 199–233. [Google Scholar] [CrossRef]
  26. Narasimhan, M.; Patel, D.; Vedpathak, D.; Rathinam, M.; Henderson, G.; Mahimainathan, L. Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells. PLoS ONE 2012, 7, e51111. [Google Scholar] [CrossRef] [Green Version]
  27. Zhang, H.A.; Gao, M.; Zhang, L.; Zhao, Y.; Shi, L.L.; Chen, B.N.; Wang, Y.H.; Wang, S.B.; Du, G.H. Salvianolic acid A protects human SH-SY5Y neuroblastoma cells against H2O2-induced injury by increasing stress tolerance ability. Biochem. Biophys. Res. Commun. 2012, 421, 479–483. [Google Scholar] [CrossRef]
  28. Heo, S.R.; Han, A.M.; Kwon, Y.K.; Joung, I. P62 protects SH-SY5Y neuroblastoma cells against H2O2-induced injury through the PDK1/Akt pathway. Neurosci. Lett. 2009, 450, 45–50. [Google Scholar] [CrossRef]
  29. González Reyes, S.; Guzmán Beltrán, S.; Medina Campos, O.N.; Pedraza Chaverri, J. Curcumin pretreatment induces Nrf2 and an antioxidant response and prevents hemin-induced toxicity in primary cultures of cerebellar granule neurons of rats. Oxid. Med. Cell. Longev. 2013, 2013, 801418. [Google Scholar] [CrossRef]
  30. Morroni, F.; Sita, G.; Graziosi, A.; Turrini, E.; Fimognari, C.; Tarozzi, A.; Hrelia, P. Protective effects of 6-(Methylsulfinyl)hexyl isothiocyanate on Aβ1-42-induced cognitive deficit, oxidative stress, inflammation, and apoptosis in mice. Int. J. Mol. Sci. 2018, 19, 2083. [Google Scholar] [CrossRef] [Green Version]
  31. Huang, S.; Meng, N.; Liu, Z.; Guo, L.; Dong, L.; Li, B.; Ye, Q. Neuroprotective effects of Taraxacum officinale Wigg. extract on glutamate-induced oxidative stress in HT22 cells via HO-1/Nrf2 pathways. Nutrients 2018, 10, 926. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Wang, L.J.; Guo, C.L.; Li, X.Q.; Wang, S.Y.; Jiang, B.; Zhao, Y.; Luo, J.; Xu, K.; Liu, H.; Guo, S.J.; et al. Discovery of novel bromophenol hybrids as potential anticancer agents through the Ros-mediated apoptotic pathway: Design, synthesis and biological evaluation. Mar. Drugs 2017, 15, 343. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Yoon, C.S.; Kim, D.C.; Lee, D.S.; Kim, K.S.; Ko, W.; Sohn, J.H.; Yim, J.H.; Kim, Y.C.; Oh, H. Anti-neuroinflammatory effect of aurantiamide acetate from the marine fungus Aspergillus sp. SF-5921: Inhibition of NF-κB and MAPK pathways in lipopolysaccharide-induced mouse BV2 microglial cells. Int. Immunopharmacol. 2014, 23, 568–574. [Google Scholar] [CrossRef] [PubMed]
  34. Vainio, M.J.; Johnson, M.S. Generating conformer ensembles using a multiobjective genetic algorithm. J. Chem. Inf. Model 2007, 47, 2462–2474. [Google Scholar]
  35. O’Boyle, N.M.; Vandermeersch, T.; Flynn, C.J.; Maguire, A.R.; Hutchison, G.R. Confab-systematic generation of diverse low-energy conformers. J. Cheminform. 2011, 3, 1–9. [Google Scholar]
  36. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Petersson, G.A.; Nakatsuji, H.; et al. (Eds.) Gaussian 16; Revision A.03; Gaussian, Inc.: Wallingford, CT, USA, 2016. [Google Scholar]
Figure 1. Structures of compounds 1 and 2.
Figure 1. Structures of compounds 1 and 2.
Marinedrugs 20 00191 g001
Figure 2. Key 2D correlations of 1 and 2.
Figure 2. Key 2D correlations of 1 and 2.
Marinedrugs 20 00191 g002
Figure 3. The ORTEP drawing structure of 1.
Figure 3. The ORTEP drawing structure of 1.
Marinedrugs 20 00191 g003
Figure 4. (A) Linear correlations between the experimental and calculated 13C NMR shifts of 2; (B) the experimental and calculated ECD spectrum of 2.
Figure 4. (A) Linear correlations between the experimental and calculated 13C NMR shifts of 2; (B) the experimental and calculated ECD spectrum of 2.
Marinedrugs 20 00191 g004
Figure 5. Plausible biosynthetic pathways for 1 and 2.
Figure 5. Plausible biosynthetic pathways for 1 and 2.
Marinedrugs 20 00191 g005
Figure 6. (A) Cell viabilities of 1 and 2 on SH-SY5Y cells with the concentration at 50 µM; (B) cytoprotective effects on H2O2 insult SH-SY5Y cells of TBHQ (10 µM), 1, or 2 with the concentration ranging from 5–50 µM; (C) compound 2 attenuated ROS accumulation in H2O2 insult SH-SY5Y cells: the morphology changes and the fluorescent signals of the control (untreated), H2O2 insult, and H2O2 and 2 (10–50 µM) co-treated cells were captured by an inverted fluorescence microscope; (D) statistical analyses of DCFH–DA fluorescence intensity on the ROS production; (E) the concentration of GSH evaluation by ELISA. TBHQ was used as the positive control. H2O2 (350 µM) was adopted to insult SH-SY5Y cells. #### p < 0.0001 vs. control group; ** p < 0.01, *** p < 0.001, and **** p < 0.0001 vs. H2O2 insult group; ns means no statistical significance. Statistical analyses were evaluated with two-way or one-way ANOVA; the values represent mean ± SD. All experiments were parallelly repeated three times in triplicate.
Figure 6. (A) Cell viabilities of 1 and 2 on SH-SY5Y cells with the concentration at 50 µM; (B) cytoprotective effects on H2O2 insult SH-SY5Y cells of TBHQ (10 µM), 1, or 2 with the concentration ranging from 5–50 µM; (C) compound 2 attenuated ROS accumulation in H2O2 insult SH-SY5Y cells: the morphology changes and the fluorescent signals of the control (untreated), H2O2 insult, and H2O2 and 2 (10–50 µM) co-treated cells were captured by an inverted fluorescence microscope; (D) statistical analyses of DCFH–DA fluorescence intensity on the ROS production; (E) the concentration of GSH evaluation by ELISA. TBHQ was used as the positive control. H2O2 (350 µM) was adopted to insult SH-SY5Y cells. #### p < 0.0001 vs. control group; ** p < 0.01, *** p < 0.001, and **** p < 0.0001 vs. H2O2 insult group; ns means no statistical significance. Statistical analyses were evaluated with two-way or one-way ANOVA; the values represent mean ± SD. All experiments were parallelly repeated three times in triplicate.
Marinedrugs 20 00191 g006
Figure 7. (A) Compound 2 promoted the Nrf2 nuclear translocation in SH-SY5Y cells. Cells were stained using DAPI and the Nrf2 antibody after being treated with 2 (50 μM) for 4 h. The represented signals were detected using the fluorescence microscope; (B) further, 2 (10–50 μM) promoted the protein expressions of Nrf2 in the cytoplasm and nucleus in H2O2 insult cells; (C) compound 2 enhanced the expressions of HO1 and NQO1 and inhibited the expression of Keap1. Protein expression levels were determined using immunoblot methods; (DF) effects of 2 promoting the mRNA expression of Keap1, HO-1, and NQO1. Cells were treated using H2O2 (350 μM) or co-treated using H2O2 (350 μM) with 2 (10–50 μM) for 24 h. The relative levels of mRNA were measured by qRT−PCR analysis. In B−F, cells were cultivated using H2O2 (350 μM) or co-cultivated using H2O2 (350 μM) with 2 (10–50 μM) for 24 h. #### p < 0.0001 vs. control (untreated cells) group; * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 vs. H2O2 insult group; ns means no statistical significance. Statistical analyses were evaluated with one-way ANOVA. The values represent mean ± SD. All experiments were parallelly repeated three times in triplicate.
Figure 7. (A) Compound 2 promoted the Nrf2 nuclear translocation in SH-SY5Y cells. Cells were stained using DAPI and the Nrf2 antibody after being treated with 2 (50 μM) for 4 h. The represented signals were detected using the fluorescence microscope; (B) further, 2 (10–50 μM) promoted the protein expressions of Nrf2 in the cytoplasm and nucleus in H2O2 insult cells; (C) compound 2 enhanced the expressions of HO1 and NQO1 and inhibited the expression of Keap1. Protein expression levels were determined using immunoblot methods; (DF) effects of 2 promoting the mRNA expression of Keap1, HO-1, and NQO1. Cells were treated using H2O2 (350 μM) or co-treated using H2O2 (350 μM) with 2 (10–50 μM) for 24 h. The relative levels of mRNA were measured by qRT−PCR analysis. In B−F, cells were cultivated using H2O2 (350 μM) or co-cultivated using H2O2 (350 μM) with 2 (10–50 μM) for 24 h. #### p < 0.0001 vs. control (untreated cells) group; * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 vs. H2O2 insult group; ns means no statistical significance. Statistical analyses were evaluated with one-way ANOVA. The values represent mean ± SD. All experiments were parallelly repeated three times in triplicate.
Marinedrugs 20 00191 g007
Figure 8. Visualization for molecular docking between 2 and 1X2R. Left: the whole perspective of the 2–1X2R complex; Right: the amplified images of 2 docking in pocket sites of 1X2R (upper: 3D graphic; lower: 2D graphic).
Figure 8. Visualization for molecular docking between 2 and 1X2R. Left: the whole perspective of the 2–1X2R complex; Right: the amplified images of 2 docking in pocket sites of 1X2R (upper: 3D graphic; lower: 2D graphic).
Marinedrugs 20 00191 g008
Figure 9. Molecular dynamics simulation analyses of RMSD and RMSF variations toward the 2–1X2R complex under a natural physiological condition: (A) the RMSD of the conformational stabilities of the complex over time; (B) the RMSF, main-chain RMSF, and side-chain RMSF of the protein backbone atoms of the complex.
Figure 9. Molecular dynamics simulation analyses of RMSD and RMSF variations toward the 2–1X2R complex under a natural physiological condition: (A) the RMSD of the conformational stabilities of the complex over time; (B) the RMSF, main-chain RMSF, and side-chain RMSF of the protein backbone atoms of the complex.
Marinedrugs 20 00191 g009
Table 1. 1H (400 MHz) and 13C (100 MHz) NMR data of compounds 1 and 2 (recorded in CDCl3).
Table 1. 1H (400 MHz) and 13C (100 MHz) NMR data of compounds 1 and 2 (recorded in CDCl3).
No.12
δHδCδHδC
2 132.67.23 d (9.8)58.5
36.45 d (9.5)48.3
4 163.0
5 163.83.91 brt (2.4)60.1
63.98 brt (2.4)60.9
7 166.6
8 168.44.66 dd (13.0, 2.3)48.9
94.38 dd (11.7, 4.0)53.6Ha 1.53 t (13.2)
Hb 2.64 dd (13.8, 2.6)
36.4
10Ha 3.46 dd (15.4, 4.2)
Hb 2.87 ddd (15.3, 11.8, 11.3)
28.2 91.1
11 106.6 198.4
12 126.7 119.6
137.42 d (7.7)118.47.59 d (8.0)125.5
147.06 td (7.6, 1.1)120.16.87 t (7.5)120.3
157.12 td (7.6, 1.1)122.57.55 d (7.7)138.7
167.25 d (7.9)111.27.17 d (8.4)110.7
17 136.3 157.7
185.27 dt (9.6, 1.3)120.75.77 d (8.6)117.9
19 139.0 139.4
201.71 d (1.1)26.21.79 s26.1
211.98 d (1.1)19.11.91 s18.8
222.38 ddt (10.5, 6.8, 3.7)32.72.29 ddt (13.7, 7.0, 3.2)32.2
230.86 d (6.8)19.00.88 d (7.1)18.7
241.02 d (7.0)16.60.52 d (6.8)16.0
25-OCH3 3.14 s52.0
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Xiao, X.; Tong, Z.; Zhang, Y.; Zhou, H.; Luo, M.; Hu, T.; Hu, P.; Kong, L.; Liu, Z.; Yu, C.; et al. Novel Prenylated Indole Alkaloids with Neuroprotection on SH-SY5Y Cells against Oxidative Stress Targeting Keap1–Nrf2. Mar. Drugs 2022, 20, 191. https://doi.org/10.3390/md20030191

AMA Style

Xiao X, Tong Z, Zhang Y, Zhou H, Luo M, Hu T, Hu P, Kong L, Liu Z, Yu C, et al. Novel Prenylated Indole Alkaloids with Neuroprotection on SH-SY5Y Cells against Oxidative Stress Targeting Keap1–Nrf2. Marine Drugs. 2022; 20(3):191. https://doi.org/10.3390/md20030191

Chicago/Turabian Style

Xiao, Xueyang, Zhou Tong, Yuexing Zhang, Hui Zhou, Mengying Luo, Tianhui Hu, Ping Hu, Luqi Kong, Zeqin Liu, Chan Yu, and et al. 2022. "Novel Prenylated Indole Alkaloids with Neuroprotection on SH-SY5Y Cells against Oxidative Stress Targeting Keap1–Nrf2" Marine Drugs 20, no. 3: 191. https://doi.org/10.3390/md20030191

APA Style

Xiao, X., Tong, Z., Zhang, Y., Zhou, H., Luo, M., Hu, T., Hu, P., Kong, L., Liu, Z., Yu, C., Huang, Z., & Hu, L. (2022). Novel Prenylated Indole Alkaloids with Neuroprotection on SH-SY5Y Cells against Oxidative Stress Targeting Keap1–Nrf2. Marine Drugs, 20(3), 191. https://doi.org/10.3390/md20030191

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop